acquired
Stage
About
Synthorx is a biotechnology company focused on engineering protein therapeutics through the expansion of the genetic code to improve drug properties.
Explore Synthorx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.